Order

Size
Price
Stock
Qty

SMT C1100

 - Ezutromid  - BMN-195
Axon 2481
CAS:  945531-77-1
Purity:  99%
  • Soluble in DMSO
  • MF:  C19H15NO3S
  • MW:  337.39

Description

SMT C1100 (Ezutromid) is an orally active utrophin upregulator developed for Duchenne muscular dystrophy research. It increases utrophin promoter activity and supports dystrophin-compensatory pathway studies.

Utrophin can functionally compensate for dystrophin at the muscle membrane, making its upregulation a therapeutic strategy for dystrophin-deficient muscle disease. SMT C1100 is useful for studying utrophin transcriptional regulation and muscle-protective pharmacology.

Key Features

  • Utrophin expression upregulator
  • Reported EC50: 0.91 µM in a utrophin A promoter reporter assay
  • Orally active in preclinical pharmacology studies
  • Relevant to dystrophin-compensation strategies in Duchenne muscular dystrophy

Applications

  • Duchenne muscular dystrophy research
  • Utrophin promoter and expression assays
  • Skeletal muscle disease models
  • Transcriptional upregulation and drug-screening studies

Related Products

AXON ID NAME FROM PRICE
1442 Caprospinol

From $121.00

1766 ICG 001

From $126.50

2084 SKL 2001

From $99.00

2120 Wnt agonist 1

From $99.00

2133 iCRT5

From $99.00

2135 iCRT14

From $143.00

2161 CCT 031374 hydrobromide

From $66.00

2378 Kartogenin

From $82.50

3715 E-7386

From $275.00

Loading...